added 2007 Thu Mar 22 7:27:24 by STONERS
Eli Lilly and Co. is pumping an additional $50 million into a partnership it created four years ago to treat multi-drug resistant tuberculosis, a disease found mostly in poor or developing countries.
Eli Lilly and Co. is pumping an additional $50 million into a partnership it created four years ago to treat multi-drug resistant tuberculosis, a disease found mostly in poor or developing countries.
